Sorrento Therapeutics, Inc. short interest in 2021
In 2021, Sorrento Therapeutics, Inc.'s disclosed short interest ran from 26.80% of shares outstanding on 15 Jan 2021 to 14.00% on 31 Dec 2021, a change of -12.80 percentage points. The year's high was 26.80% on 15 Jan 2021 and its low 14.00% on 31 Dec 2021, averaging 17.78% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 12.36 days on 28 May 2021. Full history: Sorrento Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022
2021 in figures
- Start of year
- 26.80% (15 Jan 2021)
- End of year
- 14.00% (31 Dec 2021)
- Change
- -12.80 pp
- High
- 26.80% (15 Jan 2021)
- Low
- 14.00% (31 Dec 2021)
- Average
- 17.78%
- Highest days to cover
- 12.36 (28 May 2021)
- SEC filings marked
- 4
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 26.80% | 7.80 | |
| 29 Jan 2021 | 22.83% | 1.90 | |
| 12 Feb 2021 | 22.88% | 3.15 | |
| 26 Feb 2021 | 20.31% | 4.79 | 10-K filed |
| 15 Mar 2021 | 20.00% | 4.66 | |
| 31 Mar 2021 | 19.97% | 7.17 | |
| 15 Apr 2021 | 21.24% | 7.36 | |
| 30 Apr 2021 | 19.75% | 7.92 | |
| 14 May 2021 | 18.64% | 9.15 | 10-Q filed |
| 28 May 2021 | 17.67% | 12.36 | |
| 15 Jun 2021 | 17.73% | 6.02 | |
| 30 Jun 2021 | 17.57% | 6.72 | |
| 15 Jul 2021 | 16.86% | 4.96 | |
| 30 Jul 2021 | 16.24% | 10.73 | |
| 13 Aug 2021 | 15.65% | 9.64 | 10-Q filed |
| 31 Aug 2021 | 14.52% | 8.68 | |
| 15 Sep 2021 | 14.45% | 10.01 | |
| 30 Sep 2021 | 15.32% | 10.16 | |
| 15 Oct 2021 | 15.44% | 8.61 | |
| 29 Oct 2021 | 14.89% | 10.87 | |
| 15 Nov 2021 | 14.79% | 9.28 | 10-Q filed |
| 30 Nov 2021 | 14.81% | 8.72 | |
| 15 Dec 2021 | 14.41% | 6.63 | |
| 31 Dec 2021 | 14.00% | 6.35 |
See also: Sorrento Therapeutics, Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.